2-[(2-AMINO-6-OXO-1,6-DIHYDRO-9H-PURIN-9-YL)METHOXY]ETHYL N-(BENZYLOXYCARBONYL)-L-VALINATE;Cbz-Valaciclovir;Valacyclovir Related Compound E (25 mg) (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)carbonyl]-L-valinate);N-[(Phenylmethoxy)carbonyl]-L-valine 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester;CBZ VALACYCLOVIR;2-[(2-AMino-6-oxo-1,6-dihydro-9H-purin-9-yl)Methoxy]ethyl N-(benzyloxycarbonyl)-L-valinate;Valaciclovir impurity E (PhEur);Valaciclovir Related Compound E (USP)
N-[(Phenylmethoxy)carbonyl]-L-valine 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl Ester (Valaciclovir EP Impurity E; Valaciclovir USP Related Compound E) can be used for the synthesis of L-Valacyclovir Hydrochloride (V085000), which is a drug used to treat infections caused by certain types of viruses.
Cbz-Valaciclovir Preparation Products And Raw materials
